ViroPharma, Inc. (NASDAQ:VPHM)

CAPS Rating: 4 out of 5

A biopharmaceutical company dedicated to the development and commercialization of products that address serious infectious diseases, with a focus on products used by physician specialists or in hospital settings.

Recs

1
Player Avatar sharktrade (< 20) Submitted: 11/28/2011 3:18:56 PM : Outperform Start Price: $22.90 VPHM Score: -16.44

**

Featured Broker Partners


Advertisement